메뉴 건너뛰기




Volumn 47, Issue 1, 2010, Pages 34-40

Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women

Author keywords

Cost effectiveness; Denosumab; Osteoporosis; Postmenopausal women; Treatment

Indexed keywords

DENOSUMAB;

EID: 77954759430     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.03.009     Document Type: Article
Times cited : (36)

References (52)
  • 5
    • 66249113859 scopus 로고    scopus 로고
    • Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests
    • Cleemput I., van Wilder P., Huybrechts M., Vrijens F. Belgian methodological guidelines for pharmacoeconomic evaluations: toward standardization of drug reimbursement requests. Value Health 2009, 12:441-449.
    • (2009) Value Health , vol.12 , pp. 441-449
    • Cleemput, I.1    van Wilder, P.2    Huybrechts, M.3    Vrijens, F.4
  • 6
    • 33845367564 scopus 로고    scopus 로고
    • Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model
    • Zethraeus N., Borgstrom F., Strom O., Kanis J.A., Jonsson B. Cost-effectiveness of the treatment and prevention of osteoporosis-a review of the literature and a reference model. Osteoporos Int 2007, 18:9-23.
    • (2007) Osteoporos Int , vol.18 , pp. 9-23
    • Zethraeus, N.1    Borgstrom, F.2    Strom, O.3    Kanis, J.A.4    Jonsson, B.5
  • 7
    • 67649933646 scopus 로고    scopus 로고
    • Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis
    • Hiligsmann M., Ethgen O., Bruyere O., Richy F., Gathon H.J., Reginster J.Y. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 2009, 12:687-696.
    • (2009) Value Health , vol.12 , pp. 687-696
    • Hiligsmann, M.1    Ethgen, O.2    Bruyere, O.3    Richy, F.4    Gathon, H.J.5    Reginster, J.Y.6
  • 8
    • 57049160894 scopus 로고    scopus 로고
    • Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
    • Hiligsmann M., Bruyere O., Ethgen O., Gathon H.J., Reginster J.Y. Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women. Bone 2008, 43:991-994.
    • (2008) Bone , vol.43 , pp. 991-994
    • Hiligsmann, M.1    Bruyere, O.2    Ethgen, O.3    Gathon, H.J.4    Reginster, J.Y.5
  • 9
    • 0034757430 scopus 로고    scopus 로고
    • Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy
    • Reginster J.Y., Gillet P., Gosset C. Secular increase in the incidence of hip fractures in Belgium between 1984 and 1996: need for a concerted public health strategy. Bull World Health Organ 2001, 79:942-946.
    • (2001) Bull World Health Organ , vol.79 , pp. 942-946
    • Reginster, J.Y.1    Gillet, P.2    Gosset, C.3
  • 11
    • 0034022318 scopus 로고    scopus 로고
    • Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis
    • Klotzbuecher C.M., Ross P.D., Landsman P.B., Abbott T.A., Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000, 15:721-739.
    • (2000) J Bone Miner Res , vol.15 , pp. 721-739
    • Klotzbuecher, C.M.1    Ross, P.D.2    Landsman, P.B.3    Abbott, T.A.4    Berger, M.5
  • 13
    • 3242728658 scopus 로고    scopus 로고
    • A meta-analysis of previous fracture and subsequent fracture risk
    • Kanis J.A., Johnell O., De Laet C., Johansson H., Oden A., Delmas P., et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004, 35:375-382.
    • (2004) Bone , vol.35 , pp. 375-382
    • Kanis, J.A.1    Johnell, O.2    De Laet, C.3    Johansson, H.4    Oden, A.5    Delmas, P.6
  • 14
    • 77954761936 scopus 로고    scopus 로고
    • Institut National de Statistique. Démographie mathématique. Tables de mortalité 2006 et 2004-2006. Direction Générale Statistique et Information Economique. Belgium.
    • Institut National de Statistique. Démographie mathématique. Tables de mortalité 2006 et 2004-2006. Direction Générale Statistique et Information Economique. Belgium 2008.
    • (2008)
  • 21
    • 0033938154 scopus 로고    scopus 로고
    • Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group
    • Autier P., Haentjens P., Bentin J., Baillon J.M., Grivegnee A.R., Closon M.C., et al. Costs induced by hip fractures: a prospective controlled study in Belgium. Belgian Hip Fracture Study Group. Osteoporos Int 2000, 11:373-380.
    • (2000) Osteoporos Int , vol.11 , pp. 373-380
    • Autier, P.1    Haentjens, P.2    Bentin, J.3    Baillon, J.M.4    Grivegnee, A.R.5    Closon, M.C.6
  • 22
    • 33749023290 scopus 로고    scopus 로고
    • Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries
    • Bouee S., Lafuma A., Fagnani F., Meunier P.J., Reginster J.Y. Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries. Rheumatol Int 2006, 26:1063-1072.
    • (2006) Rheumatol Int , vol.26 , pp. 1063-1072
    • Bouee, S.1    Lafuma, A.2    Fagnani, F.3    Meunier, P.J.4    Reginster, J.Y.5
  • 25
    • 43049083017 scopus 로고    scopus 로고
    • Utility values associated with osteoporotic fracture: a systematic review of the literature
    • Hiligsmann M., Ethgen O., Richy F., Reginster J.Y. Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcif Tissue Int 2008, 82:288-292.
    • (2008) Calcif Tissue Int , vol.82 , pp. 288-292
    • Hiligsmann, M.1    Ethgen, O.2    Richy, F.3    Reginster, J.Y.4
  • 27
    • 44649120398 scopus 로고    scopus 로고
    • European guidance for the diagnosis and management of osteoporosis in postmenopausal women
    • Kanis J., Burlet N., Cooper C., Delmas P.D., Reginster J.Y., Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19:399-428.
    • (2008) Osteoporos Int , vol.19 , pp. 399-428
    • Kanis, J.1    Burlet, N.2    Cooper, C.3    Delmas, P.D.4    Reginster, J.Y.5    Borgstrom, F.6
  • 28
    • 0033755942 scopus 로고    scopus 로고
    • Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
    • Kanis J.A., Johnell O., Oden A., Jonsson B., De Laet C., Dawson A. Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 2000, 27:585-590.
    • (2000) Bone , vol.27 , pp. 585-590
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3    Jonsson, B.4    De Laet, C.5    Dawson, A.6
  • 30
    • 10644229524 scopus 로고    scopus 로고
    • Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium
    • Boonen S., Kaufman J.M., Reginster J.Y., Devogelaer J.P. Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium. Osteoporos Int 2003, 14:110-115.
    • (2003) Osteoporos Int , vol.14 , pp. 110-115
    • Boonen, S.1    Kaufman, J.M.2    Reginster, J.Y.3    Devogelaer, J.P.4
  • 31
    • 0029986509 scopus 로고    scopus 로고
    • Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
    • Marshall D., Johnell O., Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996, 312:1254-1259.
    • (1996) BMJ , vol.312 , pp. 1254-1259
    • Marshall, D.1    Johnell, O.2    Wedel, H.3
  • 33
    • 52449112052 scopus 로고    scopus 로고
    • Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial
    • Miller P.D., Bolognese M.A., Lewiecki E.M., McClung M.R., Ding B., Austin M., et al. Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 2008, 43:222-229.
    • (2008) Bone , vol.43 , pp. 222-229
    • Miller, P.D.1    Bolognese, M.A.2    Lewiecki, E.M.3    McClung, M.R.4    Ding, B.5    Austin, M.6
  • 34
    • 77954761120 scopus 로고    scopus 로고
    • Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass
    • Bone H., Bolognese M., Yuen D., Kendler D., Miller P., Yang Y., et al. Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Bone Miner Res 2009, 24(Suppl 1).
    • (2009) J Bone Miner Res , vol.24 , Issue.SUPPL 1
    • Bone, H.1    Bolognese, M.2    Yuen, D.3    Kendler, D.4    Miller, P.5    Yang, Y.6
  • 36
    • 58149215739 scopus 로고    scopus 로고
    • An economic evaluation of quantitative ultrasonometry as pre-screening test for the identification of patients with osteoporosis
    • Hiligsmann M., Ethgen O., Bruyere O., Reginster J.Y. An economic evaluation of quantitative ultrasonometry as pre-screening test for the identification of patients with osteoporosis. Dis Manage Health Outcomes 2008, 16:429-438.
    • (2008) Dis Manage Health Outcomes , vol.16 , pp. 429-438
    • Hiligsmann, M.1    Ethgen, O.2    Bruyere, O.3    Reginster, J.Y.4
  • 37
    • 0034871011 scopus 로고    scopus 로고
    • A systematic review of the associations between dose regimens and medication compliance
    • Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001, 23:1296-1310.
    • (2001) Clin Ther , vol.23 , pp. 1296-1310
    • Claxton, A.J.1    Cramer, J.2    Pierce, C.3
  • 38
    • 34347406006 scopus 로고    scopus 로고
    • A systematic review of persistence and compliance with bisphosphonates for osteoporosis
    • Cramer J.A., Gold D.T., Silverman S.L., Lewiecki E.M. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007, 18:1023-1031.
    • (2007) Osteoporos Int , vol.18 , pp. 1023-1031
    • Cramer, J.A.1    Gold, D.T.2    Silverman, S.L.3    Lewiecki, E.M.4
  • 40
    • 72449152953 scopus 로고    scopus 로고
    • Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
    • Hiligsmann M., Bruyere O., Reginster J.Y. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women. Osteoporos Int 2010, 21:157-165.
    • (2010) Osteoporos Int , vol.21 , pp. 157-165
    • Hiligsmann, M.1    Bruyere, O.2    Reginster, J.Y.3
  • 41
    • 84857195304 scopus 로고    scopus 로고
    • Valeurs seuils pour le rapport coût-efficacité en soins de santé. Health Technology Assessment (HTA). Bruxelles: Centre fédéral d'expertise des soins de santé (KCE). KCE Reports 100B (D/2008/10.273/95).
    • Cleemput I, Neyt M, Thiry N, De Laet C, Leys M. Valeurs seuils pour le rapport coût-efficacité en soins de santé. Health Technology Assessment (HTA). Bruxelles: Centre fédéral d'expertise des soins de santé (KCE). KCE Reports 100B (D/2008/10.273/95).
    • Cleemput I1    Neyt M2    Thiry N3    De Laet C4    Leys, M.5
  • 42
    • 0035586112 scopus 로고    scopus 로고
    • NICE: faster access to modern treatments? Analysis of guidance on health technologies
    • Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. Br Med J 2001, 323:1300-1303.
    • (2001) Br Med J , vol.323 , pp. 1300-1303
    • Raftery, J.1
  • 43
    • 77954761079 scopus 로고    scopus 로고
    • National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008;4;437-47.
    • Tosetson AN, Melton LJ, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, et al. National Osteoporosis Foundation Guide Committee. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 2008;4;437-47.
    • Tosetson AN1    Melton LJ2    Dawson-Hughes B3    Baim S4    Favus MJ5    Khosla S6
  • 44
    • 34248642474 scopus 로고    scopus 로고
    • Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries-an economic evaluation based on the fracture intervention trial
    • Strom O., Borgstrom F., Sen S.S., Boonen S., Haentjens P., Johnell O., et al. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries-an economic evaluation based on the fracture intervention trial. Osteoporos Int 2007, 18:1047-1061.
    • (2007) Osteoporos Int , vol.18 , pp. 1047-1061
    • Strom, O.1    Borgstrom, F.2    Sen, S.S.3    Boonen, S.4    Haentjens, P.5    Johnell, O.6
  • 45
    • 0032732055 scopus 로고    scopus 로고
    • Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?
    • Bombardier C., Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?. Ann Rheum Dis 1999, 58(Suppl 1):I82-I85.
    • (1999) Ann Rheum Dis , vol.58 , Issue.SUPPL 1
    • Bombardier, C.1    Maetzel, A.2
  • 46
    • 37349075476 scopus 로고    scopus 로고
    • The cost-effectiveness of alendronate in the management of osteoporosis
    • Kanis J.A., Adams J., Borgstrom F., Cooper C., Jonsson B., Preedy D., et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone 2008, 42:4-15.
    • (2008) Bone , vol.42 , pp. 4-15
    • Kanis, J.A.1    Adams, J.2    Borgstrom, F.3    Cooper, C.4    Jonsson, B.5    Preedy, D.6
  • 47
    • 43049175471 scopus 로고    scopus 로고
    • FRAX and the assessment of fracture probability in men and women from the UK
    • Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385-397.
    • (2008) Osteoporos Int , vol.19 , pp. 385-397
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3    Johansson, H.4    McCloskey, E.5
  • 50
    • 66249124989 scopus 로고    scopus 로고
    • Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report
    • Drummond M., Barbieri M., Cook J., Glick H., Lis J., Malik F., et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health 2009, 12:409-418.
    • (2009) Value Health , vol.12 , pp. 409-418
    • Drummond, M.1    Barbieri, M.2    Cook, J.3    Glick, H.4    Lis, J.5    Malik, F.6
  • 51
    • 74249083881 scopus 로고    scopus 로고
    • Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75years
    • Hiligsmann M., Bruyere O., Reginster J.Y. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75years. Bone 2010, 46:440-446.
    • (2010) Bone , vol.46 , pp. 440-446
    • Hiligsmann, M.1    Bruyere, O.2    Reginster, J.Y.3
  • 52
    • 77954284615 scopus 로고    scopus 로고
    • Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence
    • [Electronic publication Ahead of Print]
    • Hiligsmann M., Gathon H.J., Bruyere O., Ethgen O., Rabenda V., Reginster J.Y. Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence. Value Health 2010, [Electronic publication Ahead of Print].
    • (2010) Value Health
    • Hiligsmann, M.1    Gathon, H.J.2    Bruyere, O.3    Ethgen, O.4    Rabenda, V.5    Reginster, J.Y.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.